{"transactions":[{"id":705696,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-07-20T21:04:57.000Z","date":"2026-07-16","kind":"exercise","planned":false,"acquired":false,"shares":351037,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"All options to purchase Common Stock previously held by the reporting person were cancelled on July 16, 2026.  As a result, the reporting person no longer holds options to purchase Common Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":351037},"source":{"system":"sec-edgar","filing":"0001193125-26-309048","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000119312526309048/ownership.xml","form_type":"4"}},{"id":705695,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-20T21:04:57.000Z","date":"2026-07-16","kind":"exercise","planned":false,"acquired":true,"shares":351037,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") at a price of $8.68 per share in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock is convertible to Common Stock on a one-for-one basis at the option of the holder thereof.  On July 16, 2026, the reporting person converted all 351,037 shares of Series A Convertible Preferred Stock into 351,037 shares of Common Stock."}],"balance_after":910240,"source":{"system":"sec-edgar","filing":"0001193125-26-309048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000119312526309048/ownership.xml","form_type":"4"}},{"id":1189725,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T00:38:03.000Z","date":"2025-03-25","kind":"grant","planned":false,"acquired":true,"shares":181818,"price":2.75,"value":499999.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 25, 2025, the reporting person purchased directly from the Issuer 181,818 shares of Common Stock for a total purchase price of approximately $500,000 (or $2.75 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 21, 2025 by and among the Issuer and the investors named therein."}],"balance_after":559203,"source":{"system":"sec-edgar","filing":"0000950170-25-046280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000095017025046280/ownership.xml","form_type":"4"}},{"id":1669487,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-26T21:07:52.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 15,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. These 15,000 shares are subject to vesting over a 47- month period, provided that the Reporting Person remains a consultant to the Cyclerion Therapeutics or a member of the board of directors of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions."}],"balance_after":377385,"source":{"system":"sec-edgar","filing":"0000950170-24-007920","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000095017024007920/ownership.xml","form_type":"4"}},{"id":1723756,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T21:05:10.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted 15,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. These 15,000 shares are subject to vesting over a 48- month period, provided that the Reporting Person remains a consultant to the Cyclerion Therapeutics or a member of the board of directors of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions."}],"balance_after":362385,"source":{"system":"sec-edgar","filing":"0000950170-23-067738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000095017023067738/ownership.xml","form_type":"4"}},{"id":1723755,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T21:05:10.000Z","date":"2023-11-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 20,000 shares of restricted stock pursuant to the Cyclerion Therapeutics, Inc. 2019 Equity Incentive Plan. 2,500 of the shares vest immediately and the remaining 17,500 shares are subject to vesting ratably over a 42-month period, provided that the Reporting Person remains as a director of Cyclerion Therapeutics, Inc. on such applicable vesting date, subject to certain exemptions."}],"balance_after":347385,"source":{"system":"sec-edgar","filing":"0000950170-23-067738","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000095017023067738/ownership.xml","form_type":"4"}},{"id":1882529,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2023-05-23T00:43:09.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":351037,"price":8.68,"value":3047001.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 225,000 shares of Common Stock and 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") for a total purchase price of approximately $5,000,000 (or $8.68 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock may be converted to Common Stock on a one-for-one basis at the option of the holder thereof. The reporting person has agreed not to convert his Series A Preferred Stock to the extent such conversion would require shareholder approval pursuant to Nasdaq listing rules and such shareholder approval has not been obtained."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 225,000 shares of Common Stock and 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") for a total purchase price of approximately $5,000,000 (or $8.68 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock may be converted to Common Stock on a one-for-one basis at the option of the holder thereof. The reporting person has agreed not to convert his Series A Preferred Stock to the extent such conversion would require shareholder approval pursuant to Nasdaq listing rules and such shareholder approval has not been obtained."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 225,000 shares of Common Stock and 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") for a total purchase price of approximately $5,000,000 (or $8.68 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock may be converted to Common Stock on a one-for-one basis at the option of the holder thereof. The reporting person has agreed not to convert his Series A Preferred Stock to the extent such conversion would require shareholder approval pursuant to Nasdaq listing rules and such shareholder approval has not been obtained."}],"balance_after":351037,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":351037},"source":{"system":"sec-edgar","filing":"0001140361-23-026101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036123026101/form4.xml","form_type":"4"}},{"id":1882528,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-23T00:43:09.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":8.68,"value":1953000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 19, 2023, the reporting person purchased directly from the Issuer 225,000 shares of Common Stock and 351,037 shares of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") for a total purchase price of approximately $5,000,000 (or $8.68 per share) in a private placement transaction pursuant to the Stock Purchase Agreement dated as of March 31, 2023 between the reporting person and the Issuer. The Series A Preferred Stock may be converted to Common Stock on a one-for-one basis at the option of the holder thereof. The reporting person has agreed not to convert his Series A Preferred Stock to the extent such conversion would require shareholder approval pursuant to Nasdaq listing rules and such shareholder approval has not been obtained."}],"balance_after":327385,"source":{"system":"sec-edgar","filing":"0001140361-23-026101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036123026101/form4.xml","form_type":"4"}},{"id":2427750,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-24T16:38:25.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":430000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022."}],"balance_after":430000,"derivative":{"exercise_price":1.21,"expiration_date":"2032-01-20","underlying":"Common Stock","underlying_shares":430000},"source":{"system":"sec-edgar","filing":"0001140361-22-002453","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036122002453/form4.xml","form_type":"4"}},{"id":2427749,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-24T16:38:25.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":52950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 8.33333% of the shares of Common Stock on each monthly anniversary of January 3, 2022."}],"balance_after":52950,"derivative":{"exercise_price":1.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":52950},"source":{"system":"sec-edgar","filing":"0001140361-22-002453","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036122002453/form4.xml","form_type":"4"}},{"id":2679261,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-07T21:25:44.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":823170,"price":3.28,"value":2699997.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 3, 2021, the reporting person agreed to purchase directly from the Issuer 823,170 shares of Common Stock of the Issuer in a private placement transaction."}],"balance_after":2047698,"source":{"system":"sec-edgar","filing":"0001140361-21-020090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036121020090/form4.xml","form_type":"4"}},{"id":2720848,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-10T12:45:24.000Z","date":"2021-05-06","kind":"purchase","acquired":true,"shares":302000,"price":2.43,"value":733860.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.59, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":1224528,"source":{"system":"sec-edgar","filing":"0001140361-21-016532","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036121016532/form4.xml","form_type":"4"}},{"id":2725067,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-07T01:27:00.000Z","date":"2021-05-05","kind":"purchase","acquired":true,"shares":398001,"price":2.53,"value":1006942.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.32 to $2.61, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":922528,"source":{"system":"sec-edgar","filing":"0001140361-21-016304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036121016304/form4.xml","form_type":"4"}},{"id":2725066,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-07T01:27:00.000Z","date":"2021-05-04","kind":"purchase","acquired":true,"shares":300000,"price":2.29,"value":687000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.45, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":524527,"source":{"system":"sec-edgar","filing":"0001140361-21-016304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000114036121016304/form4.xml","form_type":"4"}},{"id":3186603,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-02T20:59:10.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":153846,"price":2.65,"value":407691.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee approved the stock option award to the reporting person in order to offset his low-to-market total cash compensation and provide him with a market-aligned total compensation package for 2019, 2020, and 2021. 36,436 options under the award are intended to offset his below-market total cash salary for 2019, and 58,705 options under the award are intended to offset his below-market total cash compensation for each of 2020 and 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options, granted as an annual performance award, vests in seventy-two equal monthly installments over a six year period on each monthly anniversary of January 1, 2020 until fully vested."}],"balance_after":153846,"derivative":{"exercise_price":2.65,"expiration_date":"2030-03-31","underlying":"Common Stock","underlying_shares":153846},"source":{"system":"sec-edgar","filing":"0001209191-20-022657","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919120022657/doc4.xml","form_type":"4"}},{"id":3358723,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-11-26T22:43:59.000Z","date":"2019-11-22","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option grant will vest and become exercisable upon the attainment of both performance-based and service-based hurdles, as follows:  (i) 20% of the shares subject to the option, if the average closing price of the common stock reported by Nasdaq for any thirty (30) consecutive trading days equals or exceeds $10; plus an additional (ii) 40% of the shares, if the average closing price equals or exceeds $20; plus an additional (iii) 40% of the shares, if the average closing price equals or exceeds $30; in each case, subject to the continuous employment or service through the later of the date that the performance hurdles set forth above are attained (but no later than December 31, 2024) and December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"To the extent unvested as of December 31, 2024, all unvested shares underlying such performance-based option will be cancelled."}],"balance_after":75000,"derivative":{"exercise_price":2.01,"expiration_date":"2029-11-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-19-058165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119058165/doc4.xml","form_type":"4"}},{"id":3408994,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":857830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":857830,"derivative":{"exercise_price":14.21,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":857830},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408993,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":380330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":380330,"derivative":{"exercise_price":16.02,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":380330},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408992,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":344777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":344777,"derivative":{"exercise_price":18.47,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":344777},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408991,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":223893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":223893,"derivative":{"exercise_price":11.28,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":223893},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408990,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":37972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, granted as an annual performance award, is presently exercisable in full."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":37972,"derivative":{"exercise_price":15.54,"expiration_date":"2024-03-03","underlying":"Common Stock","underlying_shares":37972},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408989,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":43679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, granted as an annual performance award, is presently exercisable in full."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":43679,"derivative":{"exercise_price":14.4,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":43679},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408988,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":36088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, granted as an annual performance award, is presently exercisable in full."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":36088,"derivative":{"exercise_price":16.21,"expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":36088},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408987,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":53083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This report has been amended to correct the exercise price of the stock options that were originally issued by Ironwood in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, granted as an annual performance award, is presently exercisable in full."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"This report has been amended to reflect the number of options that were assumed by the Issuer under its applicable mirror equity plan as a result of the Separation."}],"balance_after":53083,"derivative":{"exercise_price":12.24,"expiration_date":"2021-02-01","underlying":"Common Stock","underlying_shares":53083},"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3408986,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-20T20:05:58.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":221736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This report has been amended to reflect the number of shares received in a pro rata distribution by Ironwood Pharmaceuticals, Inc. (\"Ironwood\")  as a result of the spin-off of the Issuer from Ironwood, effective on April 1, 2019 (the \"Separation\")."}],"balance_after":221736,"source":{"system":"sec-edgar","filing":"0001209191-19-050311","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119050311/doc4a.xml","form_type":"4/A","original_submission_date":"2019-04-03"}},{"id":3462493,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-07-12T20:09:46.000Z","date":"2019-07-10","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 20,167 shares vests in installments upon achievement of certain regulatory and commercial milestones.  The option has vested as to 2,000 shares as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":6.04,"expiration_date":"2019-07-28","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-19-041920","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119041920/doc4.xml","form_type":"4"}},{"id":3462492,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-12T20:09:46.000Z","date":"2019-07-10","kind":"exercise","acquired":true,"shares":2000,"price":6.04,"value":12080.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents the acquisition of common stock as a result of the exercise and hold of derivative securities reported in Table II."}],"balance_after":225192,"source":{"system":"sec-edgar","filing":"0001209191-19-041920","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119041920/doc4.xml","form_type":"4"}},{"id":3564761,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":857977,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2019."}],"balance_after":857977,"derivative":{"exercise_price":14.2,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":857977},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564760,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":380393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2018."}],"balance_after":380393,"derivative":{"exercise_price":16.02,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":380393},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564759,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":344829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2017."}],"balance_after":344829,"derivative":{"exercise_price":18.46,"expiration_date":"2027-02-27","underlying":"Common Stock","underlying_shares":344829},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564758,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":223919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of common stock on each monthly anniversary of January 1, 2016."}],"balance_after":223919,"derivative":{"exercise_price":11.28,"expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":223919},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564757,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":56500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":56500,"derivative":{"exercise_price":17.2,"expiration_date":"2025-03-16","underlying":"Common Stock","underlying_shares":56500},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564756,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":37973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":37973,"derivative":{"exercise_price":15.54,"expiration_date":"2024-03-03","underlying":"Common Stock","underlying_shares":37973},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564755,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":43680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":43680,"derivative":{"exercise_price":14.4,"expiration_date":"2023-02-01","underlying":"Common Stock","underlying_shares":43680},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564754,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":36089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":36089,"derivative":{"exercise_price":16.21,"expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":36089},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564753,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":53090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":53090,"derivative":{"exercise_price":12.23,"expiration_date":"2021-02-01","underlying":"Common Stock","underlying_shares":53090},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564752,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":12499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":12499,"derivative":{"exercise_price":12.39,"expiration_date":"2020-02-02","underlying":"Common Stock","underlying_shares":12499},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564751,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 20,170 shares vests in installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,000 shares as of the date hereof."}],"balance_after":2000,"derivative":{"exercise_price":6.04,"expiration_date":"2019-07-28","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564750,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":485,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The 2000 Trust for Zoe Niovi Hecht"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose."}],"balance_after":485,"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564749,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":485,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The 2000 Trust for Malcolm Paul Hecht"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose."}],"balance_after":485,"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564748,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":485,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"The 2000 Trust for Alexis Mae Hecht"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose."}],"balance_after":485,"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564747,"issuer":{"id":7698,"kind":"organization","name":"Korsana Biosciences, Inc.","symbol":"KRSA"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-04T00:30:50.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":223192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In Connection with the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the separation."}],"balance_after":223192,"source":{"system":"sec-edgar","filing":"0001209191-19-023556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023556/doc4.xml","form_type":"4"}},{"id":3564858,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":937500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The remaining 62,500 shares are presently exercisable in full."}],"balance_after":62500,"derivative":{"exercise_price":11.49,"expiration_date":"2029-01-29","underlying":"Class A Common Stock","underlying_shares":937500},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564857,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":398750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The remaining 181,250 shares are presently exercisable in full."}],"balance_after":181250,"derivative":{"exercise_price":12.95,"expiration_date":"2028-02-21","underlying":"Class A Common Stock","underlying_shares":398750},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564856,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":332500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The remaining 427,500 shares are presently exercisable in full."}],"balance_after":427500,"derivative":{"exercise_price":14.93,"expiration_date":"2027-02-27","underlying":"Class A Common Stock","underlying_shares":332500},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564855,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":166875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The remaining 723,125 shares are presently exercisable in full."}],"balance_after":723125,"derivative":{"exercise_price":9.12,"expiration_date":"2026-03-01","underlying":"Class A Common Stock","underlying_shares":166875},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564854,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":6771,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 6,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 318,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 6,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 318,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 6,771 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 318,229 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":318229,"derivative":{"exercise_price":12.56,"expiration_date":"2024-03-03","underlying":"Class A Common Stock","underlying_shares":6771},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564853,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":7645,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,645 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 367,355 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,645 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 367,355 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,645 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 367,355 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":367355,"derivative":{"exercise_price":11.65,"expiration_date":"2023-02-01","underlying":"Class A Common Stock","underlying_shares":7645},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564852,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":7533,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,533 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 292,467 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,533 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 292,467 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 7,533 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 292,467 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":292467,"derivative":{"exercise_price":13.11,"expiration_date":"2022-02-01","underlying":"Class A Common Stock","underlying_shares":7533},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564851,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":44020,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 44,020 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 130,980 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 44,020 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 130,980 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the Separation. In connection with the Separation, 44,020 shares of Class A Common Stock underlying this award were replaced with an option to purchase shares of Cyclerion Common Stock.  With respect to the remaining 130,980 shares of Class A Common Stock underlying this award, the exercise price was adjusted and the reporting person received options to purchase shares of Cyclerion Common Stock to preserve the pre-Separation intrinsic value of such portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, granted as an annual performance award, is presently exercisable in full."}],"balance_after":130980,"derivative":{"exercise_price":9.89,"expiration_date":"2021-02-01","underlying":"Class A Common Stock","underlying_shares":44020},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3564850,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-03T22:08:43.000Z","date":"2019-04-01","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents options to purchase Ironwood Class A Common Stock awarded to the reporting person prior to the separation (the \"Separation\") of Cyclerion Therapeutics, Inc. (\"Cyclerion\") from Ironwood Pharmaceuticals, Inc. (\"Ironwood\").  In connection with the Separation, the unvested portion of the Ironwood option award was replaced with an option to purchase shares of Cyclerion Common Stock.  The exercise price of the vested portion of the Ironwood option award has been adjusted, and the reporting person received additional options to purchase shares of Cyclerion Common Stock, to preserve the pre-Separation intrinsic value of the vested portion of the Ironwood option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The remaining 20,000 shares are presently exercisable in full."}],"balance_after":20000,"derivative":{"exercise_price":4.88,"expiration_date":"2019-07-28","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-023427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119023427/doc4.xml","form_type":"4"}},{"id":3608353,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-03-06T23:45:57.000Z","date":"2019-03-05","kind":"gift","acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 5, 2019, Peter M. Hecht donated the shares of common stock of Ironwood Pharmaceuticals, Inc. to a donor advised fund."}],"balance_after":2217366,"source":{"system":"sec-edgar","filing":"0001209191-19-017525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119017525/doc4.xml","form_type":"4"}},{"id":3681253,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-31T22:35:01.000Z","date":"2019-01-29","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2019."}],"balance_after":1000000,"derivative":{"exercise_price":12.9,"expiration_date":"2029-01-29","underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-19-006227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119006227/doc4.xml","form_type":"4"}},{"id":3686719,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-25","kind":"exercise","acquired":false,"shares":20449,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2013."}],"balance_after":0,"derivative":{"exercise_price":4.89,"expiration_date":"2019-02-11","underlying":"Class A Common Stock","underlying_shares":20449},"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686718,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-25","kind":"exercise","acquired":false,"shares":29551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2013."}],"balance_after":20449,"derivative":{"exercise_price":4.89,"expiration_date":"2019-02-11","underlying":"Class A Common Stock","underlying_shares":29551},"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686717,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-24","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2013."}],"balance_after":50000,"derivative":{"exercise_price":4.89,"expiration_date":"2019-02-11","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686716,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-23","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vested as to 1.25% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class A Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2013."}],"balance_after":80000,"derivative":{"exercise_price":4.89,"expiration_date":"2019-02-11","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686715,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-25","kind":"exercise","acquired":true,"shares":20449,"price":4.89,"value":99995.61,"ownership":{"direct":true},"balance_after":4717366,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686714,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-25","kind":"sale","acquired":false,"shares":29551,"price":12.23,"value":361408.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686713,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-25","kind":"exercise","acquired":true,"shares":29551,"price":4.89,"value":144504.39,"ownership":{"direct":true},"balance_after":4726468,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686712,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-24","kind":"sale","acquired":false,"shares":30000,"price":12.7,"value":381000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.39 to $13.12, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686711,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-24","kind":"exercise","acquired":true,"shares":30000,"price":4.89,"value":146700.0,"ownership":{"direct":true},"balance_after":4726917,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686710,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":30000,"price":12.66,"value":379800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $12.40 to $12.91, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3686709,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-25T23:24:39.000Z","date":"2019-01-23","kind":"exercise","acquired":true,"shares":30000,"price":4.89,"value":146700.0,"ownership":{"direct":true},"balance_after":4726917,"source":{"system":"sec-edgar","filing":"0001209191-19-005422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119005422/doc4.xml","form_type":"4"}},{"id":3708745,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-04T01:06:17.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On July 29, 2009, the Reporting Person was granted an option to purchase 40,000 shares of Class B Common Stock. The option vests in two equal installments upon the Issuer's achievement of certain regulatory and commercial milestones. The option has vested as to 20,000 shares as of the date hereof."}],"balance_after":40000,"derivative":{"exercise_price":5.48,"expiration_date":"2019-07-28","underlying":"Class A Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-001516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119001516/doc4.xml","form_type":"4"}},{"id":3708744,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-04T01:06:17.000Z","date":"2018-12-31","kind":"other","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On July 29, 2009, the Reporting Person was granted an option to purchase 40,000 shares of Class B Common Stock. The option vests in two equal installments upon the Issuer's achievement of certain regulatory and commercial milestones. The option has vested as to 20,000 shares as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":5.48,"expiration_date":"2019-07-28","underlying":"Class B Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-001516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119001516/doc4.xml","form_type":"4"}},{"id":3708743,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-04T01:06:17.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":110000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and vested as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2013"}],"balance_after":110000,"derivative":{"exercise_price":4.89,"expiration_date":"2019-02-11","underlying":"Class A Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-19-001516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119001516/doc4.xml","form_type":"4"}},{"id":3708742,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-04T01:06:17.000Z","date":"2018-12-31","kind":"other","acquired":false,"shares":110000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the conversion described in footnote (1), outstanding stock options granted pursuant to the Issuer's equity incentive plans in respect of the Issuer's Class B Common Stock remain unchanged, except that they now represent the right to receive shares of Class A Common Stock rather than shares of Class B Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and vested as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2013"}],"balance_after":0,"derivative":{"exercise_price":4.89,"expiration_date":"2019-02-11","underlying":"Class B Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-19-001516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119001516/doc4.xml","form_type":"4"}},{"id":3708741,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2019-01-04T01:06:17.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":4696917,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 31, 2018, each share of the Issuer's outstanding Class B Common Stock automatically converted into one share of the Issuer's Class A Common Stock pursuant to the Issuer's certificate of incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 31, 2018, each share of the Issuer's outstanding Class B Common Stock automatically converted into one share of the Issuer's Class A Common Stock pursuant to the Issuer's certificate of incorporation."}],"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-19-001516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119001516/doc4.xml","form_type":"4"}},{"id":3708740,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2019-01-04T01:06:17.000Z","date":"2018-12-31","kind":"other","acquired":false,"shares":4696917,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 31, 2018, each share of the Issuer's outstanding Class B Common Stock automatically converted into one share of the Issuer's Class A Common Stock pursuant to the Issuer's certificate of incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 31, 2018, each share of the Issuer's outstanding Class B Common Stock automatically converted into one share of the Issuer's Class A Common Stock pursuant to the Issuer's certificate of incorporation."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-001516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919119001516/doc4.xml","form_type":"4"}},{"id":4040336,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-22T23:07:11.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":580000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2018."}],"balance_after":580000,"derivative":{"exercise_price":14.55,"expiration_date":"2028-02-21","underlying":"Class A Common Stock","underlying_shares":580000},"source":{"system":"sec-edgar","filing":"0001209191-18-012588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919118012588/doc4.xml","form_type":"4"}},{"id":4137940,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-07","kind":"exercise","acquired":false,"shares":57405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2008 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2012."}],"balance_after":0,"derivative":{"exercise_price":3.76,"expiration_date":"2018-01-31","underlying":"Class B Common Stock","underlying_shares":57405},"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137939,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2008 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2012."}],"balance_after":57405,"derivative":{"exercise_price":3.76,"expiration_date":"2018-01-31","underlying":"Class B Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137938,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-06","kind":"exercise","acquired":false,"shares":26595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2008 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter.  The option was fully vested as of January 1, 2012."}],"balance_after":113405,"derivative":{"exercise_price":3.76,"expiration_date":"2018-01-31","underlying":"Class B Common Stock","underlying_shares":26595},"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137937,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-07","kind":"sale","acquired":false,"shares":57405,"price":15,"value":861075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise.  In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137936,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-07","kind":"exercise","acquired":true,"shares":57405,"price":3.76,"value":215842.8,"ownership":{"direct":true},"balance_after":4754322,"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137935,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":56000,"price":15.24,"value":853440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected to cover the tax liabilities arising out of the exercises of stock options of the issuer reported on this form, as well as prior exercises in which the reporting person paid the exercise price and held the underlying shares at the time of exercise.  In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $15.17 to $15.33, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137934,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":56000,"price":3.76,"value":210560.0,"ownership":{"direct":true},"balance_after":4752917,"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4137933,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-12-08T22:00:26.000Z","date":"2017-12-06","kind":"exercise","acquired":true,"shares":26595,"price":3.76,"value":99997.2,"ownership":{"direct":true},"balance_after":4696917,"source":{"system":"sec-edgar","filing":"0001209191-17-064761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117064761/doc4.xml","form_type":"4"}},{"id":4414018,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-01T23:28:50.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":760000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted as an annual performance award, vests as to 2.08333% of the shares of Class A Common Stock on each monthly anniversary of January 1, 2017."}],"balance_after":760000,"derivative":{"exercise_price":16.77,"expiration_date":"2027-02-27","underlying":"Class A Common Stock","underlying_shares":760000},"source":{"system":"sec-edgar","filing":"0001209191-17-016108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117016108/doc4.xml","form_type":"4"}},{"id":4491062,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-13T21:37:18.000Z","date":"2017-01-12","kind":"exercise","acquired":false,"shares":32994,"price":2.94,"value":97002.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2007 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2011."}],"balance_after":0,"derivative":{"exercise_price":2.94,"expiration_date":"2017-01-22","underlying":"Class B Common Stock","underlying_shares":32994},"source":{"system":"sec-edgar","filing":"0001209191-17-003679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117003679/doc4.xml","form_type":"4"}},{"id":4491061,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-01-13T21:37:18.000Z","date":"2017-01-11","kind":"exercise","acquired":false,"shares":32993,"price":2.94,"value":96999.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2007 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2011."}],"balance_after":32994,"derivative":{"exercise_price":2.94,"expiration_date":"2017-01-22","underlying":"Class B Common Stock","underlying_shares":32993},"source":{"system":"sec-edgar","filing":"0001209191-17-003679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117003679/doc4.xml","form_type":"4"}},{"id":4491060,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-01-13T21:37:18.000Z","date":"2017-01-12","kind":"sale","acquired":false,"shares":32994,"price":15.5,"value":511407.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.25 to $15.66, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4670322,"source":{"system":"sec-edgar","filing":"0001209191-17-003679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117003679/doc4.xml","form_type":"4"}},{"id":4491059,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-01-13T21:37:18.000Z","date":"2017-01-12","kind":"exercise","acquired":true,"shares":32994,"price":2.94,"value":97002.36,"ownership":{"direct":true},"balance_after":4703316,"source":{"system":"sec-edgar","filing":"0001209191-17-003679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117003679/doc4.xml","form_type":"4"}},{"id":4491058,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-01-13T21:37:18.000Z","date":"2017-01-11","kind":"sale","acquired":false,"shares":32993,"price":15.84,"value":522609.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.  In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.24, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4670322,"source":{"system":"sec-edgar","filing":"0001209191-17-003679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117003679/doc4.xml","form_type":"4"}},{"id":4491057,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":29504,"kind":"person","name":"Hecht Peter M","position":1,"cik":"0001478485","reported_name":"Hecht Peter M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class B Common Stock","published_at":"2017-01-13T21:37:18.000Z","date":"2017-01-11","kind":"exercise","acquired":true,"shares":32993,"price":2.94,"value":96999.42,"ownership":{"direct":true},"balance_after":4703315,"source":{"system":"sec-edgar","filing":"0001209191-17-003679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478485/000120919117003679/doc4.xml","form_type":"4"}}]}